Posted by Michael Wonder on 05 Dec 2016
Nocdurna approved by TGA
5 December 2016 - The TGA has approved a new indication for Ferring's desmopressin acetate.
The TGA approved Nocdurna (desmopressin acetate) on 2 December 2016 for the treatment of nocturia due to idiopathic nocturnal polyuria in adults who awaken two or more times each night to void and have not responded to lifestyle measures.
